These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24032487)

  • 41. Changes in insulin sensitivity and insulin secretion with the sodium glucose cotransporter 2 inhibitor dapagliflozin.
    Mudaliar S; Henry RR; Boden G; Smith S; Chalamandaris AG; Duchesne D; Iqbal N; List J
    Diabetes Technol Ther; 2014 Mar; 16(3):137-44. PubMed ID: 24237386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of insulin detemir dose frequency on clinical outcomes in patients with diabetes in PREDICTIVE.
    Fontaine P; Gin H; Pinget M; Thivolet C; Hanaire H; Robert JJ; Marre M; Venkatanarasimhachar S
    Adv Ther; 2009 May; 26(5):535-51. PubMed ID: 19513632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of adding once-daily insulin glulisine in Japanese type 2 diabetes patients treated with insulin glargine and sitagliptin.
    Takahara M; Shiraiwa T; Katakami N; Matsuoka TA; Shimomura I
    Diabetes Technol Ther; 2014 Oct; 16(10):633-9. PubMed ID: 24949654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.
    Kovatchev B; Cobelli C; Renard E; Anderson S; Breton M; Patek S; Clarke W; Bruttomesso D; Maran A; Costa S; Avogaro A; Dalla Man C; Facchinetti A; Magni L; De Nicolao G; Place J; Farret A
    J Diabetes Sci Technol; 2010 Nov; 4(6):1374-81. PubMed ID: 21129332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the impact of hematocrit and other interference on the accuracy of hospital-based glucose meters.
    Karon BS; Griesmann L; Scott R; Bryant SC; Dubois JA; Shirey TL; Presti S; Santrach PJ
    Diabetes Technol Ther; 2008 Apr; 10(2):111-20. PubMed ID: 18260774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glycemic Tracking Before and After Insulin Pump Initiation.
    Johnson A; Hill NE; Godsland I; Oliver NS
    J Diabetes Sci Technol; 2020 Sep; 14(5):970-971. PubMed ID: 32146846
    [No Abstract]   [Full Text] [Related]  

  • 47. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.
    Esposito K; Ciotola M; Maiorino MI; Gualdiero R; Schisano B; Ceriello A; Beneduce F; Feola G; Giugliano D
    Ann Intern Med; 2008 Oct; 149(8):531-9. PubMed ID: 18936501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Continuous Glucose Monitoring in People With Type 1 Diabetes on Multiple-Dose Injection Therapy: The Relationship Between Glycemic Control and Hypoglycemia.
    Oliver N; Gimenez M; Calhoun P; Cohen N; Moscardo V; Hermanns N; Freckmann G; Reddy M; Heinemann L
    Diabetes Care; 2020 Jan; 43(1):53-58. PubMed ID: 31530662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of a computer-assisted insulin protocol on glycemic control in a surgical intensive care unit.
    Barletta JF; McAllen KJ; Eriksson EA; Deines G; Blau SA; Thayer SC; Senagore AJ
    Diabetes Technol Ther; 2011 Apr; 13(4):495-500. PubMed ID: 21355721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multicenter user evaluation of ACCU-CHEK® Combo, an integrated system for continuous subcutaneous insulin infusion.
    Kerr D; Hoogma RP; Buhr A; Petersen B; Storms FE;
    J Diabetes Sci Technol; 2010 Nov; 4(6):1400-7. PubMed ID: 21129336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blood glucose controller for neonatal intensive care: virtual trials development and first clinical trials.
    Le Compte A; Chase JG; Lynn A; Hann C; Shaw G; Wong XW; Lin J
    J Diabetes Sci Technol; 2009 Sep; 3(5):1066-81. PubMed ID: 20144420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pramlintide improved measures of glycemic control and body weight in patients with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion therapy.
    Herrmann K; Frias JP; Edelman SV; Lutz K; Shan K; Chen S; Maggs D; Kolterman OG
    Postgrad Med; 2013 May; 125(3):136-44. PubMed ID: 23748514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A study of patient experience using a blood glucose meter with an in-built insulin dose calculator.
    Ramtoola S; Jude E; Robinson A; Malik I; Rayman G; Dang C; RossMartin GD; Ali A
    J Diabetes Sci Technol; 2014 Jul; 8(4):776-82. PubMed ID: 24876430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system.
    Jones SM; Quarry JL; Caldwell-McMillan M; Mauger DT; Gabbay RA
    Diabetes Technol Ther; 2005 Apr; 7(2):233-40. PubMed ID: 15857224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequency of mealtime insulin bolus predicts glycated hemoglobin in youths with type 1 diabetes.
    Patton SR; DeLurgio SA; Fridlington A; Cohoon C; Turpin AL; Clements MA
    Diabetes Technol Ther; 2014 Aug; 16(8):519-23. PubMed ID: 24773597
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
    Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
    Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin pump therapy in pregnant women with type 1 diabetes mellitus.
    Roman G
    Rom J Intern Med; 2004; 42(2):465-8. PubMed ID: 15529637
    [No Abstract]   [Full Text] [Related]  

  • 58. Accuracy of five systems for self-monitoring of blood glucose in the hands of adult lay-users and professionals applying ISO 15197:2013 accuracy criteria and potential insulin dosing errors.
    Jendrike N; Baumstark A; Pleus S; Liebing C; Kamecke U; Haug C; Freckmann G
    Curr Med Res Opin; 2019 Feb; 35(2):301-311. PubMed ID: 29927663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carbohydrate-to-insulin ratio is estimated from 300-400 divided by total daily insulin dose in type 1 diabetes patients who use the insulin pump.
    Kuroda A; Yasuda T; Takahara M; Sakamoto F; Kasami R; Miyashita K; Yoshida S; Kondo E; Aihara K; Endo I; Matsuoka TA; Kaneto H; Matsumoto T; Shimomura I; Matsuhisa M
    Diabetes Technol Ther; 2012 Nov; 14(11):1077-80. PubMed ID: 23101953
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
    Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
    J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.